Lucid Diagnostics (LUCD) Return on Sales (2021 - 2026)

Lucid Diagnostics' Return on Sales history runs 6 years deep, the most recent figure standing at 0.11% for Q1 2026.

• Quarterly Return on Sales rose 22.0% year-over-year to 0.11% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.09% (up 6.0% YoY) and the FY2025 annual result came in at 0.12%, down 2.0% from the prior year.
• Return on Sales was 0.11% for Q1 2026 at Lucid Diagnostics, up from 0.11% in the prior quarter.
• Across five years, Return on Sales topped out at 0.04% in Q2 2025 and bottomed at 1.89% in Q3 2022.
• A 5-year average of 0.41% and a median of 0.11% in 2024 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales sank 154 bps — and 2023, when it jumped 171 bps.
• Lucid Diagnostics' Return on Sales stood at 1.33% in 2022, then surged by 92 bps to 0.1% in 2023, then increased by 7 bps to 0.1% in 2024, then dropped by 13 bps to 0.11% in 2025, then increased by 1 bps to 0.11% in 2026.
• Business Quant data shows LUCD's Return on Sales at 0.11% in Q1 2026, 0.11% in Q4 2025, and 0.09% in Q3 2025.